Bio Solution Co.,Ltd. (KOSDAQ:086820)
11,470
+70 (0.61%)
At close: Apr 28, 2026
Bio Solution Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2020 | FY 2019 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 11,883 | 12,922 | 3,393 | 1,510 |
Short-Term Investments | 211.66 | 228.26 | - | 7,000 |
Trading Asset Securities | - | 1,200 | 32,812 | 31,970 |
Cash & Short-Term Investments | 12,094 | 14,350 | 36,204 | 40,480 |
Cash Growth | -15.72% | -60.36% | -10.56% | - |
Accounts Receivable | 4,901 | 4,753 | 2,726 | 3,416 |
Other Receivables | 983.04 | 76.88 | 76.54 | 156.9 |
Receivables | 5,899 | 4,830 | 2,803 | 3,573 |
Inventory | 1,252 | 1,492 | 1,328 | 529.81 |
Other Current Assets | 160.74 | 310.95 | 352.07 | 210.52 |
Total Current Assets | 19,406 | 20,983 | 40,687 | 44,793 |
Property, Plant & Equipment | 4,446 | 6,450 | 5,230 | 4,105 |
Long-Term Investments | 39,190 | 34,752 | 0 | 0 |
Other Intangible Assets | 862.75 | 740.09 | 830.46 | 847.15 |
Long-Term Accounts Receivable | - | 64.42 | 0 | -0 |
Long-Term Deferred Charges | 3,010 | 2,851 | 1,282 | 292.11 |
Other Long-Term Assets | 1,235 | 1,181 | 1,769 | 1,770 |
Total Assets | 68,481 | 67,464 | 49,798 | 51,807 |
Accounts Payable | 255.66 | 458.67 | 195.36 | 98.93 |
Accrued Expenses | 223.07 | 201.62 | 165.83 | 164.79 |
Short-Term Debt | 29,953 | 29,576 | - | - |
Current Portion of Leases | 826.59 | 943.63 | 781.17 | 610.9 |
Other Current Liabilities | 2,952 | 2,204 | 878.29 | 1,937 |
Total Current Liabilities | 34,210 | 33,384 | 2,021 | 2,812 |
Long-Term Leases | 131.52 | 970.61 | 653.01 | 150.49 |
Pension & Post-Retirement Benefits | 1,290 | 994.09 | 334.37 | 525.1 |
Other Long-Term Liabilities | 845.78 | 858.39 | 125.99 | 223.53 |
Total Liabilities | 36,477 | 36,207 | 3,134 | 3,711 |
Common Stock | 12,146 | 4,072 | 4,046 | 4,018 |
Additional Paid-In Capital | 55,152 | 62,876 | 57,062 | 56,478 |
Retained Earnings | -37,888 | -38,116 | -14,676 | -12,706 |
Comprehensive Income & Other | 2,594 | 2,426 | 233.03 | 306.39 |
Shareholders' Equity | 32,003 | 31,257 | 46,664 | 48,097 |
Total Liabilities & Equity | 68,481 | 67,464 | 49,798 | 51,807 |
Total Debt | 30,911 | 31,490 | 1,434 | 761.4 |
Net Cash (Debt) | -18,817 | -17,140 | 34,770 | 39,718 |
Net Cash Growth | - | - | -12.46% | - |
Net Cash Per Share | -757.19 | -712.72 | 1455.34 | 1683.89 |
Filing Date Shares Outstanding | 27.03 | 24.07 | 23.91 | 23.75 |
Total Common Shares Outstanding | 27.03 | 24.07 | 23.91 | 23.75 |
Working Capital | -14,804 | -12,401 | 38,667 | 41,981 |
Book Value Per Share | 1183.84 | 1298.56 | 1951.26 | 2025.35 |
Tangible Book Value | 31,141 | 30,517 | 45,834 | 47,249 |
Tangible Book Value Per Share | 1151.93 | 1267.81 | 1916.54 | 1989.68 |
Machinery | 5,298 | 5,857 | 5,596 | 4,595 |
Construction In Progress | 516 | 1,961 | 1,229 | 856.1 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.